Skip to main content

Table 1 Relationship between the relative expression of circADARB1 in plasma of NKTCL patients and the characteristics of clinical data

From: CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3

Clinical characteristics

Group

Cases

P-value

Age

 < 60

43

0.584

 ≥ 60

7

Sex

Male

32

0.613

Female

18

B symptom

With

26

0.497

Without

24

Stage

I–II

38

0.525

III–IV

12

PINK-E

Low

40

0.933

Intermediate and High

10

ECOG

0–2

44

0.610

3–5

6

Response to therapy

CR, PR

37

0.041

SD, PD

13